Papadaki, M.A.; Messaritakis, I.; Fiste, O.; Souglakos, J.; Politaki, E.; Kotsakis, A.; Georgoulias, V.; Mavroudis, D.; Agelaki, S.
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Int. J. Mol. Sci. 2021, 22, 925.
https://doi.org/10.3390/ijms22020925
AMA Style
Papadaki MA, Messaritakis I, Fiste O, Souglakos J, Politaki E, Kotsakis A, Georgoulias V, Mavroudis D, Agelaki S.
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. 2021; 22(2):925.
https://doi.org/10.3390/ijms22020925
Chicago/Turabian Style
Papadaki, Maria A., Ippokratis Messaritakis, Oraianthi Fiste, John Souglakos, Eleni Politaki, Athanasios Kotsakis, Vassilis Georgoulias, Dimitrios Mavroudis, and Sofia Agelaki.
2021. "Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)" International Journal of Molecular Sciences 22, no. 2: 925.
https://doi.org/10.3390/ijms22020925
APA Style
Papadaki, M. A., Messaritakis, I., Fiste, O., Souglakos, J., Politaki, E., Kotsakis, A., Georgoulias, V., Mavroudis, D., & Agelaki, S.
(2021). Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences, 22(2), 925.
https://doi.org/10.3390/ijms22020925
